Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tezacaftor/Ivacaftor in Children 6-11 Years with Cystic Fibrosis
NCT03559062Phase 3Completed
- Sponsor
- Vertex Pharmaceuticals
- Start
- May 2018
- Primary completion
- Dec 2018
- Modality
- Small Molecules
- Countries
- 9
01
Overview
A Phase 3 trial of tezacaftor in cystic fibrosis (CF), sponsored by Vertex Pharmaceuticals. Started May 2018; status: completed.
02
Drugs
tezacaftor
03
Conditions
cystic fibrosis (CF)
Beyond the preview
Go deeper on NCT03559062.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03559062.